Z, F., S, A., F, P., & CG, M. (2016). Tocilizumab in refractory rheumatoid arthritis: Long-term efficacy, safety, and tolerability beyond 2 years. Dove Medical Press.
Cita Chicago Style (17a ed.)Z, Farah, Ali S, Price-Kuehne F, y Mackworth-Young CG. Tocilizumab in Refractory Rheumatoid Arthritis: Long-term Efficacy, Safety, and Tolerability Beyond 2 Years. Dove Medical Press, 2016.
Cita MLA (8a ed.)Z, Farah, et al. Tocilizumab in Refractory Rheumatoid Arthritis: Long-term Efficacy, Safety, and Tolerability Beyond 2 Years. Dove Medical Press, 2016.
Precaución: Estas citas no son 100% exactas.